Fennec Pharmaceuticals (TSX:FRX) Other Financing : C$0.98 Mil (TTM As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Fennec Pharmaceuticals Other Financing?

Fennec Pharmaceuticals's Other Financing for the three months ended in Sep. 2024 was C$0.00 Mil.

Fennec Pharmaceuticals's Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.98 Mil.

Fennec Pharmaceuticals Other Financing Historical Data

The historical data trend for Fennec Pharmaceuticals's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fennec Pharmaceuticals Other Financing Chart

Fennec Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Financing

Get a 7-Day Free Trial

0.41

-0.03

1.08

2.20

Fennec Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Financing	Get a 7-Day Free Trial															-	0.98	-	-	-

Fennec Pharmaceuticals Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.98 Mil.

Fennec Pharmaceuticals Other Financing Related Terms

Thank you for viewing the detailed overview of Fennec Pharmaceuticals's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Fennec Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fennec Pharmaceuticals Inc (TSX:FRX) » Definitions » Other Financing

Comparable Companies

Traded in Other Exchanges

FENC:USA RV41:Germany

Address

68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709

Website

https://www.fennecpharma.com

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Executives

Robert Christopher Andrade	Senior Officer
Rostislav Christov Raykov	Director, Senior Officer
Adrian J. Haigh	Senior Officer
Chris Anigeron Rallis	Director
Khalid Islam	Director